Our Technology Enables Efficient Hit-to-Lead Workflows
Bicoll developed an efficient and multi-disciplinary technology approach to drug discovery. It supports pre-clinical research from the discovery of drug targets to lead optimization – the initial stage of the R&D process. Bicoll prepares researched, validated, and actionable insights to get through the discovery and optimization process to obtain the highest quality lead compounds.
Bicoll owns a proprietary small molecule property-based isolation technology to identify beneficial compounds (Bifrac N™ and Bipreselect™). The workflow with these technologies turns plant extracts into promising set of small molecules, so-called plant “Profiles™”. The resulting Profiles™, which can be selected and assembled according to the test system, are fully compatible with HTS and cell based assay systems.
Our innovative strategies combine proprietary in-house technology platform with scientific expertise to guide innovations from discovery to lead optimization. The rapid selection of the best lead compound, which exhibit superior drug-like profiles for further development cycles, is the strength of Bicoll’s workflow. Subsequent medicinal chemistry and custom synthesis complement company expertise.